Financial Year |
March 31 2023 |
Monetary Funds |
278,999,840.31 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
-- |
Accounts Receivable |
520,508,875.22 |
Advances to Suppliers |
122,019,818.48 |
Other Receivables |
783,328.05 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
279,148,953.81 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
59,093,442.97 |
Total Current Assets |
1,337,779,218.29 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
1,713,790,874.11 |
Under-construction Projects |
493,243,280.00 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
231,227,205.58 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
1,777,373.04 |
Deferred Income Tax Assets |
16,964,089.05 |
Other Non-Current Assets |
62,447,267.62 |
Sub-Total of Non-Current Assets |
2,520,982,683.65 |
Total Assets |
3,858,761,901.94 |
Short-Term Loans |
582,540,060.91 |
Trading Financial liabilities |
-- |
Notes Payable |
42,902,629.96 |
Accounts Payable |
231,434,485.28 |
Accounts Received In Advance |
6,825,282.89 |
Employee Compensation Payable |
3,719,736.19 |
Taxes Payable |
30,752,302.13 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
5,605.77 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
346,138,086.86 |
Other Current Liabilities |
284,250.58 |
Sub-Total of Current Liabilities |
1,249,094,978.70 |
Long-term Loans |
476,115,000.00 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
2,442,942.69 |
Deferred Income Tax Liabilities |
8,725,038.32 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
524,134,566.24 |
Total Liabilities |
1,773,229,544.94 |
Paid-In Capital(Or Share Stock) |
642,380,414.00 |
Capital Surplus |
348,234,954.87 |
Surplus Reserve |
101,195,678.17 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
988,118,529.92 |
Minority Stockholder's Interest |
2,164,763.37 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,083,367,593.63 |
Owner's Equity(Stockholder's Equity) |
2,085,532,357.00 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
3,858,761,901.94 |